Ranbaxy Laboratories has received an approval from the Therapeutic Goods Administration (TGA), Department of Health and Ageing of the Australian Government, for the registration of Ozidal Risperidone 0.5, 1, 2, 3 and 4 mg tablets in Australia.
The details can be read here.
No comments:
Post a Comment